Clinical predictors of survival in real world practice in stage IV melanoma

BACKGROUND AND AIM: While studies continually identify new clinical prognostic factors in stage IV melanoma, the introduction of targeted and immunotherapies have revolutionised the prognosis of advanced melanoma since 2011. The study aims to investigate the prognostic significance of past and newly...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Hsien‐Pang, Archer, Christine, Yip, Desmond, Peters, Geoffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939985/
https://www.ncbi.nlm.nih.gov/pubmed/36161287
http://dx.doi.org/10.1002/cnr2.1691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939985/
https://www.ncbi.nlm.nih.gov/pubmed/36161287
http://dx.doi.org/10.1002/cnr2.1691

Ejemplares similares